Has Spencer Stott received payments from drug or device companies?

Yes. Drug and device makers reported $4,751 in general payments to Spencer Stott across 236 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Spencer Stott did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Spencer Stott come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Spencer Stott

Psychiatric/Mental Health · Gilbert, AZNPI 1699445601

Payments from drug & device makers

$4,751in general payments, 2019–2025

Across 236 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Vanda Pharmaceuticals Inc.$507
Alkermes, Inc.$406
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$374
Otsuka America Pharmaceutical, Inc.$368
Bausch Health US, LLC$242
plus $1K from 17 others

What the payments were for

Food & beverage$4,748100%
Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	94	$1,637
Vanda Pharmaceuticals Inc.	19	$507
Alkermes, Inc.	11	$406
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	19	$374
Otsuka America Pharmaceutical, Inc.	19	$368
Bausch Health US, LLC	12	$242
Lundbeck LLC	9	$186
Axsome Therapeutics, Inc.	11	$170
Corium, LLC	9	$144
Neurocrine Biosciences, Inc.	1	$110
Johnson & Johnson	5	$103
Takeda Pharmaceuticals U.S.A., Inc.	5	$82
Ironshore Pharmaceuticals Inc.	4	$81
Noven Therapeutics, LLC	4	$68
E.r. Squibb & Sons, L.L.C.	3	$64
Biogen	2	$47
Tris Pharma Inc	2	$38
Avanir Pharmaceuticals, Inc.	2	$28
Acadia Pharmaceuticals Inc	1	$24
Vertical Pharmaceuticals, LLC	1	$19
Supernus Pharmaceuticals, Inc.	1	$19
Neos Therapeutics, LP	1	$16
Idorsia Pharmaceuticals US Inc	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LYBALVI$834
Fanapt$247
VRAYLAR$244
INGREZZA$110

How this compares

$4,751 in reported general payments places this provider in the 90th percentile of 1,230 psychiatric/mental health providers in Arizona.

See all psychiatric/mental health providers in Arizona →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	22	$1,198
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	13	$480

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Gilbert

Diane StrickerGilbert$281K
Roya NayeriGilbert$15K
Ann CaseyGilbert$7K
Nicole LyonsGilbert$7K
Landis StokumGilbert$7K
Jeffrey ScottGilbert$7K
Rachel EagerGilbert$7K
Marcus DanielsGilbert$6K
Sarah ButtlesGilbert$6K
Melanie LaubGilbert$5K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →